Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 163 participants.
Also called NCT05911685
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 163 participants
- Registry
-
NCT05911685
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05911685. Allocation not applicable; no masking; primary purpose treatment. Start 2019-03-26 (actual); primary completion 2021-01-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder
- Condition
- Atrial Fibrillation
- Intervention (Device)
- SeaLA™ left atrial appendage occluder
- Lead sponsor
- Hangzhou Dinova EP Technology Co., Ltd
Record details
- Record id
cardio:ct-nct05911685- Content hash
19c506f9b6512f12f065d91fd6a53fa42eca6fff7ef37282aa3d0d9003310560